Arctostaphylos uva-ursi (Bearberry)

Bearberry (Arctostaphylos uva-ursi) contains arbutin, which converts to hydroquinone in alkaline urine to provide antimicrobial effects against urinary tract pathogens. The herb also contains gallic acid and flavonoids that contribute to its antioxidant properties.

Origin & History

Arctostaphylos uva-ursi, commonly known as bearberry, is a low-growing evergreen shrub native to northern regions of the United States, Canada, Europe, and Asia. The medicinal parts are dried leaves harvested between October and December when arbutin content peaks, typically processed into powder or hydroalcoholic extracts standardized to 7-9% arbutin content.

Historical & Cultural Context

Bearberry leaves have centuries of documented use in Native American, European, and other traditional medicine systems for diuretic, astringent, and urinary antiseptic properties. Historical applications include treatment of chronic cystitis, nephritis, kidney stones, and bronchitis, with commercial harvesting occurring across California, Spain, and northern North America.

Health Benefits

• Urinary tract antiseptic properties - Traditional use supported by arbutin's hydrolysis to hydroquinone which exerts antimicrobial effects in urine (evidence quality: traditional use only)
• Potential antioxidant activity - Phenolic compounds including gallic acid and flavonoids may provide free radical scavenging effects (evidence quality: preliminary, mechanism-based)
• Diuretic effects - Historically used across Native American and European traditions for increasing urine flow (evidence quality: traditional use only)
• Astringent properties - High tannin content (up to 72.58 mg/g) provides astringent effects traditionally used for tissue tightening (evidence quality: traditional use only)
• Kidney stone prevention - Traditional use for preventing kidney stones, though no clinical trials validate this claim (evidence quality: traditional use only)

How It Works

Arbutin, the primary active compound in bearberry, undergoes hydrolysis in alkaline urine to form hydroquinone, which exerts direct antimicrobial effects against gram-positive and gram-negative bacteria. The phenolic compounds including gallic acid and quercetin scavenge free radicals through electron donation. Additional tannins provide astringent properties that may support urinary tract tissue integrity.

Scientific Research

The research dossier reveals a notable absence of human clinical trials, RCTs, or meta-analyses for bearberry, with no PubMed PMIDs available for specific studies. Available data focus primarily on chemical composition analysis and traditional use documentation rather than rigorous clinical outcomes or efficacy measurements.

Clinical Summary

Clinical evidence for bearberry remains limited, with most support derived from traditional use rather than controlled trials. Small observational studies suggest potential benefits for recurrent urinary tract infections when combined with alkalinizing agents. In vitro studies demonstrate antimicrobial activity against E. coli and other uropathogens, but human clinical trials with adequate sample sizes are lacking. The European Medicines Agency recognizes bearberry for short-term urinary discomfort based on traditional use evidence.

Nutritional Profile

Bearberry leaf (the primary medicinal part) is not consumed as a food source, so macronutrient profiling is not nutritionally relevant; however, its key bioactive compounds are well-characterized. Arbutin (hydroquinone glucoside) is the primary active constituent, present at approximately 5–15% dry weight in leaves, with some reports citing up to 17% in high-quality specimens. Upon oral ingestion, arbutin is hydrolyzed in the gut and urine to free hydroquinone, which exerts antimicrobial activity specifically in alkaline urine. Methyl arbutin is also present at lower concentrations (1–3% dry weight). Tannins are abundant, comprising 15–20% dry weight, predominantly gallotannins and ellagitannins including corilagin, which contribute astringent properties and may reduce gastrointestinal absorption of other compounds (bioavailability-limiting effect). Gallic acid and ellagic acid are present as free phenolic acids at approximately 0.5–2% dry weight. Flavonoids including quercetin, isoquercitrin, hyperoside, and myricetin are present at roughly 1–2% combined dry weight. Ursolic acid (a pentacyclic triterpenoid) is found at approximately 0.4–0.7% dry weight. Allantoin is present in trace amounts. Tannin content significantly impacts bioavailability of arbutin by potentially binding to intestinal transporters; alkaline urine pH is required for optimal hydroquinone antimicrobial activity post-hydrolysis. Preparations are typically aqueous infusions or standardized extracts; cold-water infusions are sometimes preferred to reduce tannin extraction while retaining arbutin content.

Preparation & Dosage

No clinically studied dosage ranges are available from human trials. Commercial preparations typically use crude leaf powder or extracts standardized to 7-9% arbutin content, though specific evidence-based dosing protocols are absent from the literature. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Cranberry extract, D-mannose, Vitamin C, Uva ursi, Marshmallow root

Safety & Interactions

Bearberry is generally well-tolerated for short-term use but may cause nausea, vomiting, and stomach irritation in some individuals. Hydroquinone formation raises concerns about potential liver toxicity with prolonged use exceeding 1 week or repeated courses. The herb may interact with medications that acidify urine, reducing its effectiveness, and should be avoided during pregnancy and breastfeeding due to insufficient safety data. Individuals with kidney or liver disease should consult healthcare providers before use.